Parallax Volatility Advisers
BLFS icon

Parallax Volatility Advisers’s BioLife Solutions BLFS Stock Holding History

Parallax Volatility Advisers’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-816
Closed -$28.7K – 3008
2021
Q1 		$29K Buy
+816
New +$32.3K ﹤0.01% 3019

Other funds holding BLFS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

Parallax Volatility Advisers's BLFS Position: Q2 2021 in Review

Parallax Volatility Advisers sold out of BioLife Solutions (BLFS) in Q2 2021, closing a stake of 816 shares — an estimated $28.7K sold.

Parallax Volatility Advisers first reported a position in BLFS in Q1 2021 and held it in 1 quarter. The position peaked at $29K in Q1 2021. 132 funds tracked by Wall St. Rank hold BLFS as of Q2 2021.

  • Parallax Volatility Advisers reported no remaining BioLife Solutions position as of Q2 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 816 BioLife Solutions shares in Q2 2021, an estimated $28.7K.
  • Parallax Volatility Advisers first reported a position in BioLife Solutions in Q1 2021 and held it in 1 quarter.
  • Parallax Volatility Advisers's BioLife Solutions position peaked at $29K in Q1 2021.
  • 132 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2021.

Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.